The 1990 patent

Researched and compiled by the Irlen Wiki editorial team · First published 9 November 2026 · Revised 9 November 2026

In brief: Helen L. Irlen’s U.S. patent 4,961,640 for tinted lenses was filed in 1985, granted on 9 October 1990, and has expired.^[1]

The record

Details are from the patent record; Google Patents notes that its listed status and dates are not legal conclusions.^[1]

What it describes

The abstract says specially tinted lenses benefit patients with visual disturbance caused by what it calls a recently identified functional disorder, the Irlen Syndrome of scotopic sensitivity, in people who show over-stimulation of receptor cells in the wavelength band of 425 to 575 nanometers.^[1] The description says relief depends mainly on the tint and only secondarily on optical density, and that a primary pink or peach tint combined with blue, green, gray, purple, goldenrod or yellow tints often gives relief.^[1]

Expiry

Google Patents lists the patent as expired, with an anticipated expiration of 9 October 2007, seventeen years after grant, consistent with the 17-year term that applied to older U.S. patents.^[1][2] The Institute still describes its testing process as patented in its FAQ; that statement is reported as the Institute’s.^[3]

Context

The Institute’s founder page says Irlen spent five years after her initial finding refining it and patenting a set of colored filters.^[4] Wikipedia notes that she submitted the patent in 1985.^[5] ABC News described the Institute as having patented colored filters for the syndrome.^[6]

What a patent does and does not show

A patent grants exclusive rights to an invention; it is not evidence that a treatment works. The patent’s claim of receptor over-stimulation in the scotopic range has not been confirmed, and EyeWiki calls the term scotopic sensitivity syndrome scientifically inaccurate because there is no evidence the symptoms come from rod dysfunction.^[7]

Who holds it

Google Patents lists both the original and the current assignee as an individual rather than a company, with Helen L. Irlen as inventor; it cautions that its assignee listings may be inaccurate.^[1] The record does not name the Irlen Institute or Perceptual Development Corporation. Because the patent has expired, the tinting approach it describes is no longer protected by it, although the Irlen name and product names remain the Institute’s branding.^[1][8]

Today

The Institute now uses the names Irlen Spectral Filters for its tinted lenses and Irlen Colored Overlays and Irlen Clings for its overlays, and marks the Irlen name as a registered trademark on its website.^[9][10][8]

Common questions

Further pages

• Spectral filters
• Helen Irlen
• History
• Irlen syndrome
• Colored overlays

Citations

1. ^ ^{a b c d e f g} US4961640A: Method and apparatus of treatment of symptoms of the Irlen syndrome. Google Patents (U.S. Patent and Trademark Office record). Retrieved 9 November 2026.
2. ^ Patent term in the United States. Wikipedia. Retrieved 9 November 2026.
3. ^ FAQs. Irlen Institute (irlen.com). Retrieved 9 November 2026.
4. ^ Founder Helen Irlen. Irlen Institute (irlen.com). Retrieved 9 November 2026.
5. ^ Irlen syndrome. Wikipedia. Retrieved 9 November 2026.
6. ^ Irlen syndrome, the condition medical experts say doesn’t exist, promoted to school teachers (26 June 2019). ABC News (Australia). Retrieved 9 November 2026.
7. ^ Meares-Irlen syndrome/visual stress (MISViS), reviewed 25 September 2026. EyeWiki, American Academy of Ophthalmology. Retrieved 9 November 2026.
8. ^ ^{a b} The Irlen Institute: home page. Irlen Institute (irlen.com). Retrieved 9 November 2026.
9. ^ Irlen colored filters. Irlen Institute (irlen.com). Retrieved 9 November 2026.
10. ^ Irlen colored overlays. Irlen Institute (irlen.com). Retrieved 9 November 2026.